A. Bucceri et al., PREGNANCY OUTCOME AMONG HIV-POSITIVE AND NEGATIVE INTRAVENOUS-DRUG-USERS, European journal of obstetrics, gynecology, and reproductive biology, 72(2), 1997, pp. 169-174
Objective: To analyze determinants of pregnancy outcome, among HIV inf
ected and uninfected intravenous drug users. Study design: A total of
315 pregnant current intravenous drug users, IVDU (151 HIV infected an
d 164 HIV uninfected subjects) were referred to the Center for Pregnan
t Drug Addicts of the Mangiagalli Clinic, Milan, Italy, for internatal
care and delivery between 1985 and 1993. Results: HIV uninfected and
infected mothers did not differ significantly according to type of pre
gnancy, gestational age at childbirth, mode of delivery, pregnancy out
come and newborn weight, height, head circumference, sex and Apgar at
1 and 5 min. Out of 133 children (born to HIV infected mothers) for wh
om HIV status was available, 20 (15%) were HIV infected or developed A
IDS-related signs and symptoms during a 24 months follow-up. The distr
ibution of HIV infected and non infected infants was not significantly
different as regards maternal CD4 lymphocyte count, week of gestation
at birth, mode of delivery, infant weight, height, head circumference
and Apgar at 1 and 5 min. Conclusion: Our data show that HIV infected
women in the early stages of HIV infection are not at a higher risk o
f adverse course of pregnancy than HIV uninfected women. Vertical tran
smission rates were not associated to newborn characteristics. (C) 199
7 Elsevier Science Ireland Ltd.